Latest Quark Stories
FREMONT, Calif., Aug. 3 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that James D.
FREMONT, Calif., May 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "PF-04523655 (REDD14NP), an siRNA Compound Targeting RTP801, Penetrates Retinal Cells Producing Target Gene Knockdown and Avoiding TLR3 Activation," at the Association for Research in Vision and...
Several years after Duke University researchers announced spectacular behavior of a low density ultracold gas cloud, researchers at Brookhaven National Laboratory have observed strikingly similar properties in a very hot and dense plasma "fluid" created to simulate conditions when the universe was about one millionths of a second old.
Presentation to Highlight Results of Ocular Neuroprotection Candidate FREMONT, Calif., Dec.
Soeren Prell and a team of Iowa State University researchers are part of an international research team testing a theory that led to a share of the 2008 Nobel Prize in Physics for Japanese researchers Makoto Kobayashi and Toshihide Maskawa.
By Dennis Overbye A U.S. and two Japanese physicists won the Nobel Prize in Physics on Tuesday for their work exploring the hidden symmetries between elementary particles that are the deepest constituents of nature.
By Dan Vergano Insights into the peculiarities of the smallest subatomic particles and the existence of the universe have netted one American and two Japanese theorists the 2008 Nobel Prize in physics.
Two Japanese scientists and a Japanese-born American have been awarded the 2008 Nobel Prize in physics for their work with subatomic particles which provided new insights into the nature of matter.
Quark, a developer of desktop publishing and dynamic publishing software, has acquired the assets of In.vision Research, a software company that develops add-in to Microsoft Word for XML authoring.
Quark Inc., announced today that it has acquired the assets of In.vision Research Corporation, a Florida-based software company that develops the industry-leading add-in to Microsoft(R) Word for XML authoring.